James CLOYD,Angela BIRNBAUM,Ilo LEPPIK,Stephen D. COLLINS
申请号：
US13679715
公开号：
US20130072476A1
申请日:
2012.11.16
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention is directed to a carbamazepine-cyclodextrin inclusion complex useful for the parenteral administration of carbamazepine. The carbamazepine-cyclodextrin inclusion complex is prepared by the admixture of a modified cyclodextrin and carbamazepine in a physiologically acceptable fluid. Modified cyclodextrins include 2-hydroxypropyl-beta-cyclodextrin and sulfoalkyl cyclodextrins. More particularly, the sulfoalkyl cyclodextrins are those described and disclosed in U.S. Pat. Nos. 5,134,127 and 5,376,645. A physiologically acceptable fluid includes sterile isotonic water, Ringers lactate, D5W (5% dextrose in water), physiological saline, and similar fluids suitable for parenteral administration.
